Ionis Pharma (NASDAQ: IONS) reported Q4 EPS of $0.02, $0.01 better than the analyst estimate of $0.01. Revenue for the quarter came in at $172.3 million versus the consensus estimate of $124.69 million.

For earnings history and earnings-related data on Ionis Pharma (IONS) click here.